News

Retina specialists Caesar Luo, MD, of Bay Area Retina Associates (Walnut Creek, CA) and S.K. Steven Houston III, MD, of Florida Retina Institute, share their outlooks on retina innovation in the "year of the eye" amid a global pandemic.

Diagnosing a 'down looker'

To prepare students and their families for the new school year, the American Academy of Ophthalmology is sharing a back-to-online school checklist to help prevent digital eye strain.

COVID-19 pandemic is accelerating cultural paradigm shift for medical professionals

Following cataract surgery, the dropless option is proving to be a preferred method during recovery

The FDA this week granted the fourth Orphan Drug Designation for a novel gene therapy product candidate (OCU400, Ocugen Inc.) in the treatment of PDE6B gene mutation-associated retinal diseases.

Researchers note that more study of conjunctivitis is needed in patients with COVID-19

Gene therapy to treat choroideremia shows potential for maintaining or improving vision

Dilraj Grewal, MD, speaks on his presentation "Evaluating the True 3-Year Recurrence Rate in Non-infectious Posterior Segment Uveitis Following an Injectable Fluocinolone Acetonide Insert," during ASRS 2020.

Machine-learning algorithms have potential to predict patients with nonproliferative diabetic retinopathy who will or will not improve over time.

Study results demonstrate effectiveness in treating dry age-related macular degeneration

This action will result in 2 separate companies,

An ophthalmologist details how the COVID-19 crisis has helped him focus on essentials

Intravitreal injection offers safety, efficacy, and improved vision in patients

Chronic cases can be difficult for retinal specialists, but treatment is satisfying.

Justis P. Ehlers, MD, speaks on the key findings and take-aways from his presentation "Impact of baseline OCT characteristics on response to risuteganib for the treatment of intermediate age-related macular degeneration (AMD)."

Reduced quality of life, mental health issues are major adverse effects of TED

For many physicians, "moral injury" may be an actual issue

Daniel F. Kiernan, MD, FACS, speaks on the key findings and take-aways of his presentation "Dexamethasone intracameral drug-delivery suspension for inflammation associated with vitreoretinal surgery."

S.K. Steven Houston III, MD, discusses retina innovations in use in his practice, including the NGENUITY 1.4 upgrade from Alcon, and adapting to ever-changing operating room spacing and set-up in the COVID-19 environment

Caesar Luo, MD, shares the take-away points from his ASRS presentation, and how the topics from his talk may be applied day to day in retinal practice.

An inhaled formulation of interferon beta, significantly decreased the chances of hospitalized patients developing severe COVID-19 compared to placebo.

Ancient election offers lesson to modern voters

Theresa Heah, MD, provides an update on AsclepiX’s AXT107, which is derived from a cryptic peptide within collagen IV that works by activating naturally existing, homeostatic mechanisms of angiogenesis.

The Ophthalmology Times Resident Writers Award Program is a competitive writing program showcasing the best case studies in anterior segment.

According to a study presented at the American Society of Ophthalmic Trauma conference, patients are experiencing domestic injuries, delaying care, traveling for care, and have less insurance.

How gonioscopy can offer ophthalmologists an option in treating patients with glaucoma

As more novel ophthalmic drugs and devices become available under the CMS “pass-through”designation, practices should be proactive in embracing these products.